Topiramate Tablet
Product Images NDC 63187-228

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 63187-228). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43e1322a-figure-01 (43e1322a Figure 01)

FDA Label Image

43e1322a-figure-02 (43e1322a Figure 02)

43e1322a-figure-02 (43e1322a Figure 02)
Cumulative rates for time to first seizure for patients treated with topiramate at a dose of 50 mg/day (N=234) and topiramate at a dose of 400 mg/day (N=236).*
FDA Label Image

43e1322a-figure-03 (43e1322a Figure 03)

FDA Label Image

Image 01

Image 01
This is a medication called Topiramate 50mg with NDC number 63187-228-30, which comes in a pack of 30 tablets. The tablets are yellow, round, and film-coated, with IG and 279 imprinted on each side. The medication guide should be dispensed with the tablets. The lot number is 00000, and the expiry date is 00/00/00. The medication should be stored at room temperature, between 20°-25°C, and kept out of reach of children. It is manufactured by Ascent Pharmaceuticals and packaged by Proficient Rx LP in Thousand Oaks, CA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.